Cardiac Ablation Market Report 2026

Cardiac Ablation Market Overview

• Cardiac Ablation market size has reached to $4.9 billion in 2025 • Expected to grow to $9.24 billion in 2030 at a compound annual growth rate (CAGR) of 13.4% • Growth Driver: Rising Incidence Of Cardiac Diseases Fueling The Growth Of The Market Due To Increasing Need For Effective Rhythm Management • Market Trend: Integration Of Mapping And Ablation For Enhanced Precision • North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Cardiac Ablation Market?

Cardiac ablation is a minimally invasive surgery that treats abnormal heartbeats, or arrhythmias. The treatment involves creating microscopic scars in specific areas of the heart tissue to block or eliminate faulty electrical pathways that cause the arrhythmia. Cardiac ablation is performed using heat (radiofrequency) or cold (cryoablation) and is commonly used when medications are ineffective or cause significant side effects. The main product types of cardiac ablation are radiofrequency (RF) ablators, electrical ablators, cryoablation devices, ultrasound ablators, and others. Radiofrequency (RF) ablators are medical devices that use heat from radiofrequency energy to destroy abnormal tissue, commonly used in cancer treatment, pain management, and cardiac arrhythmia correction. These devices incorporate various technologies, including conventional technology, advanced technology, hybrid technology, and robotic-assisted technology, and find applications in atrial fibrillation and flutter, tachycardia, and others, serving end users including hospitals, ambulatory surgical centers, cardiac centers, and others.

What Is The Cardiac Ablation Market Growth Forecast?

The cardiac ablation market size is expected to see rapid growth in the next few years. It will grow to $9.24 billion in 2030 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to technological advancements in robotic-assisted and hybrid ablation, rising adoption of cryoablation and pulsed field ablation systems, increasing cardiac centers and ambulatory surgical setups, growing geriatric population with arrhythmia risk, expansion of training programs for cardiac specialists. Major trends in the forecast period include increasing adoption of minimally invasive cardiac procedures, rising demand for robotic-assisted ablation devices, growth in atrial fibrillation and tachycardia treatments, expansion of hybrid and advanced ablation technologies, enhanced focus on patient safety and procedure efficiency.

Global Cardiac Ablation Market Segmentation

1) By Product Type: Radiofrequency (RF) Ablators, Electrical Ablators, Cryoablation Devices, Ultrasound Ablators, Other Product Types 2) By Technology: Conventional Technology, Advanced Technology, Hybrid Technology, Robotic-Assisted Technology 3) By Application: Atrial Fibrillation And Flutter, Tachycardia, Other Applications 4) By End User: Hospitals, Ambulatory Surgical Centers, Cardiac Centers, Other End Users Subsegments: 1) By Radiofrequency (RF) Ablators: Conventional RF Ablation Catheters, Irrigated-Tip RF Ablation Catheters, Temperature-Controlled RF Ablation Systems 2) By Electrical Ablators: Direct Current (DC) Ablators, Pulsed Field Ablation (PFA) Systems 3) By Cryoablation Devices: Cryoballoons, Cryoablation Catheters, Cryosurgical Units 4) By Ultrasound Ablators: High-Intensity Focused Ultrasound (HIFU) Devices, Intracardiac Echocardiography (ICE)-Guided Ablators 5) By Other Product Types: Microwave Ablation Systems, Laser Ablation Systems, Hybrid Ablation Devices

What Is The Driver Of The Cardiac Ablation Market?

The rising incidence of cardiac diseases is expected to drive the growth of the cardiac ablation market going forward. Cardiac diseases refer to a range of conditions that affect the heart's structure and function, including coronary artery disease, heart failure, and arrhythmias. The rising incidence of cardiac diseases is due to sedentary lifestyles, which contribute to obesity, hypertension, and poor cardiovascular health. Cardiac ablation aids in cardiac disease management by precisely targeting and eliminating faulty electrical pathways in the heart. It improves patient outcomes by restoring normal rhythm, reducing symptoms like palpitations and fatigue, and decreasing reliance on long-term medication. For instance, in October 2023, according to the World Economic Forum, a Switzerland-based non-profit organization, by 2050, the number of stroke deaths could rise by 50%. Therefore, the rising incidence of cardiac diseases is driving the growth of the cardiac ablation industry.

Key Players In The Global Cardiac Ablation Market

Major companies operating in the cardiac ablation market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, GE HealthCare, Boston Scientific Corporation, Olympus Corporation, CathRx Ltd., Teleflex Incorporated, CONMED Corporation, Lepu Medical Technology Beijing Co. Ltd., MicroPort Scientific Corporation, AtriCure Inc., Japan Lifeline Co. Ltd., AngioDynamics Inc., Biotronik SE, Biosense Webster, Medicover Medical Technologies, Stereotaxis Inc, Cardiofocus Inc, Rhythmia Medical Systems

Global Cardiac Ablation Market Trends and Insights

Major companies operating in the cardiac ablation market are focusing on developing innovative solutions, such as next‑generation pulsed‑field ablation (PFA) systems with integrated mapping, to meet the rising demand for safer, more efficient, and anatomically precise treatment of atrial fibrillation and other arrhythmias. Pulsed‑field ablation is a non‑thermal ablation technology that uses ultra‑short, high‑voltage electrical pulses to induce electroporation in cardiac myocardial cells, thereby selectively destroying arrhythmogenic tissue while minimizing collateral damage to adjacent structures (such as the esophagus, phrenic nerve, or pulmonary veins) in contrast to traditional thermal ablation methods like radiofrequency (RF) or cryoablation, which rely on heat or freezing and carry higher risks of off‑target injury. For instance, in October 2024, Abbott Laboratories, a US-based medical device company, launched its Advisor HD Grid X Mapping Catheter, Sensor Enabled, which received FDA clearance to support both PFA and RF ablation cases by providing advanced high-density mapping. This catheter features a grid design with multiple small, closely spaced electrodes to deliver high-resolution electrical mapping of cardiac anatomy, enabling precise localisation of target tissue and better guidance during ablation particularly valuable in complex PFA workflows where accurate mapping can improve the safety and efficacy of lesion creation.

What Are Latest Mergers And Acquisitions In The Cardiac Ablation Market?

In January 2025, Boston Scientific Corporation, a US-based healthcare technology company, acquired Cortex Inc., for an undisclosed amount. With this acquisition, Boston Scientific Corporation sought to strengthen its electrophysiology (EP) portfolio by adding Cortex’s advanced cardiac mapping solution to better guide atrial fibrillation (AFib) ablation procedures and improve treatment precision. Cortex Inc., is a US-based medical technology company that specialises in developing diagnostic and mapping systems using proprietary algorithms and basket catheters to identify arrhythmogenic sources in AFib.

Regional Outlook

North America was the largest region in the cardiac ablation market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Cardiac Ablation Market?

The cardiac ablation market consists of revenues earned by entities by providing services such as electrophysiological mapping, pre- and post-operative diagnostics, patient monitoring, and follow-up care for the management of cardiac arrhythmias. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac ablation market also includes sales of ablation catheters, ablation generators, energy device systems, mapping and navigation systems, and accessory devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.